Search research articles
Contact Us
Filters
Showing results (11-20 of 31) with videos related to
Page
of 4
Sort By:
Journal of Clinical Pharmacy and Therapeutics
|
December 29, 1998
Determination of compatibility and stability of drugs used in palliative care
D Schrijvers, C Tai-Apin, M C De Smet, et al.
Immunogenetics
|
January 1, 1994
Sequence and expression pattern of the human MAGE2 gene
C De Smet, C Lurquin, P van der Bruggen, et al.
Immunogenetics
|
January 1, 1992
Mapping of the genes encoding tum- transplantation antigens P91A, P35B, and P198
P J Dyson, C de Smet, A M Knight, et al.
Cancer Research
|
March 4, 1998
Identification of a new MAGE gene with tumor-specific expression by representational difference analysis
S Lucas, C De Smet, K C Arden, et al.
Oncogene
|
March 3, 2009
Subtelomeric DNA hypomethylation is not required for telomeric sister chromatid exchanges in ALT cells
G Tilman, A Loriot, A Van Beneden, et al.
Neuropathology and Applied Neurobiology
|
November 26, 2003
CDKN2A, CDKN2B and p14ARF are frequently and differentially methylated in ependymal tumours
E Rousseau, M-M Ruchoux, F Scaravilli, et al.
International Journal of Cancer
|
June 17, 1998
LAGE-1, a new gene with tumor specificity
B Lethé, S Lucas, L Michaux, et al.
Immunogenetics
|
January 1, 1995
Involvement of two Ets binding sites in the transcriptional activation of the MAGE1 gene
C De Smet, S J Courtois, I Faraoni, et al.
The Journal of Investigative Dermatology
|
July 1, 1996
The majority of autologous cytolytic T-lymphocyte clones derived from peripheral blood lymphocytes of a melanoma patient recognize an antigenic peptide derived from gene Pmel17/gp100
H Zarour, C De Smet, F Lehmann, et al.
Eye (London, England)
|
January 1, 1997
Genes coding for melanoma antigens recognised by cytolytic T lymphocytes
C De Smet, C Lurquin, E De Plaen, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 31) with videos related to
Sort By:
Page
of 4
Journal of Clinical Pharmacy and Therapeutics
|
December 29, 1998
Determination of compatibility and stability of drugs used in palliative care
D Schrijvers, C Tai-Apin, M C De Smet, et al.
Immunogenetics
|
January 1, 1994
Sequence and expression pattern of the human MAGE2 gene
C De Smet, C Lurquin, P van der Bruggen, et al.
Immunogenetics
|
January 1, 1992
Mapping of the genes encoding tum- transplantation antigens P91A, P35B, and P198
P J Dyson, C de Smet, A M Knight, et al.
Cancer Research
|
March 4, 1998
Identification of a new MAGE gene with tumor-specific expression by representational difference analysis
S Lucas, C De Smet, K C Arden, et al.
Oncogene
|
March 3, 2009
Subtelomeric DNA hypomethylation is not required for telomeric sister chromatid exchanges in ALT cells
G Tilman, A Loriot, A Van Beneden, et al.
Neuropathology and Applied Neurobiology
|
November 26, 2003
CDKN2A, CDKN2B and p14ARF are frequently and differentially methylated in ependymal tumours
E Rousseau, M-M Ruchoux, F Scaravilli, et al.
International Journal of Cancer
|
June 17, 1998
LAGE-1, a new gene with tumor specificity
B Lethé, S Lucas, L Michaux, et al.
Immunogenetics
|
January 1, 1995
Involvement of two Ets binding sites in the transcriptional activation of the MAGE1 gene
C De Smet, S J Courtois, I Faraoni, et al.
The Journal of Investigative Dermatology
|
July 1, 1996
The majority of autologous cytolytic T-lymphocyte clones derived from peripheral blood lymphocytes of a melanoma patient recognize an antigenic peptide derived from gene Pmel17/gp100
H Zarour, C De Smet, F Lehmann, et al.
Eye (London, England)
|
January 1, 1997
Genes coding for melanoma antigens recognised by cytolytic T lymphocytes
C De Smet, C Lurquin, E De Plaen, et al.
Page
of 4